Bartlett & Co Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Hold |
587
| – | – | ﹤0.01% | 409 |
|
|
2025
Q1 | $285K | Buy |
587
+230
| +64% | +$112K | ﹤0.01% | 403 |
|
|
2024
Q4 | $144K | Hold |
357
| – | – | ﹤0.01% | 490 |
|
|
2024
Q3 | $166K | Buy |
357
+6
| +2% | +$2.79K | ﹤0.01% | 473 |
|
|
2024
Q2 | $165K | Buy |
351
+96
| +38% | +$45K | ﹤0.01% | 460 |
|
|
2024
Q1 | $107K | Buy |
255
+55
| +28% | +$23K | ﹤0.01% | 542 |
|
|
2023
Q4 | $81.9K | Hold |
200
| – | – | ﹤0.01% | 606 |
|
|
2023
Q3 | $69.5K | Hold |
200
| – | – | ﹤0.01% | 595 |
|
|
2023
Q2 | $70.4K | Hold |
200
| – | – | ﹤0.01% | 600 |
|
|
2023
Q1 | $63K | Hold |
200
| – | – | ﹤0.01% | 535 |
|
|
2022
Q4 | $57.8K | Hold |
200
| – | – | ﹤0.01% | 560 |
|
|
2022
Q3 | $57.9K | Hold |
200
| – | – | ﹤0.01% | 546 |
|
|
2022
Q2 | $56.4K | Hold |
200
| – | – | ﹤0.01% | 551 |
|
|
2022
Q1 | $52.2K | Buy |
+200
| New | +$52.2K | ﹤0.01% | 578 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | -$807 | – | 1082 |
|
|
2021
Q2 | $807 | Sell |
4
-50
| -93% | -$10.1K | ﹤0.01% | 978 |
|
|
2021
Q1 | $11.6K | Hold |
54
| – | – | ﹤0.01% | 712 |
|
|
2020
Q4 | $12.8K | Buy |
54
+4
| +8% | +$945 | ﹤0.01% | 708 |
|
|
2020
Q3 | $13.6K | Hold |
50
| – | – | ﹤0.01% | 658 |
|
|
2020
Q2 | $14.5K | Buy |
+50
| New | +$14.5K | ﹤0.01% | 646 |
|
|
2019
Q3 | – | Sell |
-34
| Closed | -$6.24K | – | 938 |
|
|
2019
Q2 | $6.24K | Buy |
+34
| New | +$6.24K | ﹤0.01% | 617 |
|